| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25021-259-50 | 25021-259 | HUMAN PRESCRIPTION DRUG | Nelarabine | Nelarabine | INJECTION, SOLUTION | INTRAVENOUS | 20240801 | N/A | ANDA | ANDA212605 | Sagent Pharmaceuticals | NELARABINE | 5 mg/mL | 1 VIAL in 1 CARTON (25021-259-50) / 50 mL in 1 VIAL |
| 25021-259-51 | 25021-259 | HUMAN PRESCRIPTION DRUG | Nelarabine | Nelarabine | INJECTION, SOLUTION | INTRAVENOUS | 20240801 | N/A | ANDA | ANDA212605 | Sagent Pharmaceuticals | NELARABINE | 5 mg/mL | 6 VIAL in 1 CARTON (25021-259-51) / 50 mL in 1 VIAL |
| 68083-233-06 | 68083-233 | HUMAN PRESCRIPTION DRUG | Nelarabine | Nelarabine | INJECTION | INTRAVENOUS | 20240103 | N/A | ANDA | ANDA212605 | Gland Pharma Limited | NELARABINE | 5 mg/mL | 6 VIAL, SINGLE-DOSE in 1 CARTON (68083-233-06) / 50 mL in 1 VIAL, SINGLE-DOSE (68083-233-01) |